Literature DB >> 26870170

Effect of overexpression of HOX genes on its invasive tendency in cerebral glioma.

Yun-Bao Guo1, Yi-Meng Shao2, Jing Chen3, Song-Bai Xu1, Xing-Dong Zhang4, Mao-Ren Wang5, Hai-Yan Liu4.   

Abstract

Transcription factors encoded by HOX genes are vital in the determination of cell fate and identity during embryonic development. In certain malignancies, HOX genes also behave as oncogenes. The present study demonstrated suppression of the invasive tendency of glioblastoma multiforme U-118 and U-138 cells by the introduction of the antisense fragments of HOXA6 and B13 genes using electroporation. The invasion index indicated 79 and 72% reductions in the invasive ability of antisense HOXA6 and B13, respectively. No significant differences in the invasive index of the parental and mock cells of each HOX gene were observed (invasive index, 0.75-0.91; P=0.05). A reduction in invasion tendency was also observed following betulinic acid (BA) treatment: The results from the matrigel assay analysis clearly demonstrated a significant inhibition in the invasive behaviour of U-118 and U-138 cell lines from day 15 following BA treatment, with a maximum effect on day 30. The invasion index demonstrated 62 and 65% reductions in invasion ability in the U-118 and U-138 cell lines, respectively. The suppression of HOXC6 and B13 expression by the introduction of the corresponding antisense fragments in addition to BA reduced invasion tendency in U-118 and U-138 cell lines. The mechanism underlying the association between the HOX gene and invasive behavior in glioma cells is yet to be understood. However, the anti-invasive behavior of BA may aid understanding of the mechanism in future studies.

Entities:  

Keywords:  betulinic acid; glioblastoma multiforme; homeobox genes; invasion ability

Year:  2015        PMID: 26870170      PMCID: PMC4727036          DOI: 10.3892/ol.2015.3893

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  36 in total

1.  Hox D3 expression in normal and impaired wound healing.

Authors:  L A Uyeno; J A Newman-Keagle; I Cheung; T K Hunt; D M Young; N Boudreau
Journal:  J Surg Res       Date:  2001-09       Impact factor: 2.192

2.  Early mitotic degradation of the homeoprotein HOXC10 is potentially linked to cell cycle progression.

Authors:  Davide Gabellini; Ivan N Colaluca; Hartmut C Vodermaier; Giuseppe Biamonti; Mauro Giacca; Arturo Falaschi; Silvano Riva; Fiorenzo A Peverali
Journal:  EMBO J       Date:  2003-07-15       Impact factor: 11.598

3.  Homeotic genes and the evolution of arthropods and chordates.

Authors:  S B Carroll
Journal:  Nature       Date:  1995-08-10       Impact factor: 49.962

4.  Immunocytochemical detection of the homeobox B3, B4, and C6 gene products in childhood medulloblastomas/primitive neuroectodermal tumors.

Authors:  B Bodey; B Bodey; S E Siegel; H E Kaiser
Journal:  Anticancer Res       Date:  2000 May-Jun       Impact factor: 2.480

Review 5.  Classification of glioblastoma multiforme in adults by molecular genetics.

Authors:  Ramsis Benjamin; Joanna Capparella; Alice Brown
Journal:  Cancer J       Date:  2003 Mar-Apr       Impact factor: 3.360

6.  HOX gene expression in normal and neoplastic human kidney.

Authors:  C Cillo; P Barba; G Freschi; G Bucciarelli; M C Magli; E Boncinelli
Journal:  Int J Cancer       Date:  1992-07-30       Impact factor: 7.396

7.  HOX gene expression in human small-cell lung cancers xenografted into nude mice.

Authors:  C Tiberio; P Barba; M C Magli; F Arvelo; T Le Chevalier; M F Poupon; C Cillo
Journal:  Int J Cancer       Date:  1994-08-15       Impact factor: 7.396

8.  Aberrant HOXC expression accompanies the malignant phenotype in human prostate.

Authors:  Gary J Miller; Heidi L Miller; Adrie van Bokhoven; James R Lambert; Priya N Werahera; Osvaldo Schirripa; M Scott Lucia; Steven K Nordeen
Journal:  Cancer Res       Date:  2003-09-15       Impact factor: 12.701

9.  Induction of the angiogenic phenotype by Hox D3.

Authors:  N Boudreau; C Andrews; A Srebrow; A Ravanpay; D A Cheresh
Journal:  J Cell Biol       Date:  1997-10-06       Impact factor: 10.539

View more
  6 in total

1.  PiggyBac mutagenesis and exome sequencing identify genetic driver landscapes and potential therapeutic targets of EGFR-mutant gliomas.

Authors:  Imran Noorani; Jorge de la Rosa; Yoon Ha Choi; Alexander Strong; Hannes Ponstingl; M S Vijayabaskar; Jusung Lee; Eunmin Lee; Angela Richard-Londt; Mathias Friedrich; Federica Furlanetto; Rocio Fuente; Ruby Banerjee; Fengtang Yang; Frances Law; Colin Watts; Roland Rad; George Vassiliou; Jong Kyoung Kim; Thomas Santarius; Sebastian Brandner; Allan Bradley
Journal:  Genome Biol       Date:  2020-07-30       Impact factor: 13.583

2.  Identification of IDH-mutant gliomas by a prognostic signature according to gene expression profiling.

Authors:  Qiangwei Wang; Zhiliang Wang; Guanzhang Li; Chuanbao Zhang; Zhaoshi Bao; Zheng Wang; Gan You; Tao Jiang
Journal:  Aging (Albany NY)       Date:  2018-08-15       Impact factor: 5.955

3.  Overexpression of HOXC6 promotes cell proliferation and migration via MAPK signaling and predicts a poor prognosis in glioblastoma.

Authors:  PengYu Yang; Wei Kang; YaWen Pan; XianJun Zhao; Lei Duan
Journal:  Cancer Manag Res       Date:  2019-09-03       Impact factor: 3.989

4.  Oncogenic and tumor suppressor function of MEIS and associated factors.

Authors:  Birkan Gİrgİn; Medine KaradaĞ-Alpaslan; Fatih KocabaŞ
Journal:  Turk J Biol       Date:  2020-12-14

5.  Coexpression of HOXA6 and PBX2 promotes metastasis in gastric cancer.

Authors:  Jianjiao Lin; Huiqiong Zhu; Linjie Hong; Weimei Tang; Jing Wang; Hongsong Hu; Xiaosheng Wu; Yaying Chen; Guangnan Liu; Qiong Yang; Jiaying Li; Yusi Wang; Zhizhao Lin; Yizhi Xiao; Weiyu Dai; Miaojvan Huang; Guoxin Li; Aimin Li; Jide Wang; Li Xiang; Side Liu
Journal:  Aging (Albany NY)       Date:  2021-02-01       Impact factor: 5.682

6.  Systematic analysis of enhancer regulatory circuit perturbation driven by copy number variations in malignant glioma.

Authors:  Jun Xiao; Xiaoyan Jin; Chunlong Zhang; Haozhe Zou; Zhenghong Chang; Nan Han; Xia Li; Yunpeng Zhang; Yongsheng Li
Journal:  Theranostics       Date:  2021-01-01       Impact factor: 11.556

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.